title: Advances in advanced prostate cancer - the continuing journey.
authors.affiliation: Department of Oncology, University College Hospital London, London, UK.
authors.forename: Heather
authors.initials: H
authors.lastname: Payne
authors.affiliation: Department of Oncology, University College Hospital London, London, UK.
authors.forename: Reena
authors.initials: R
authors.lastname: Davda
authors.affiliation: Institute of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK.
authors.forename: Robert
authors.initials: R
authors.lastname: Jones
authors.affiliation: Department of Medical Oncology, University Hospital Southampton, Southampton, UK.
authors.forename: Simon
authors.initials: S
authors.lastname: Crabb
authors.affiliation: British Uro-Oncology Group, London, UK.
authors.forename: Janis
authors.initials: J
authors.lastname: Troup
authors.affiliation: Department of Oncology, Guy's Hospital, London, UK.
authors.forename: Simon
authors.initials: S
authors.lastname: Hughes
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D018450:Disease Progression; D000077143:Docetaxel; D004359:Drug Therapy, Combination / Q000639:trends; D019317:Evidence-Based Medicine; D006801:Humans; D008297:Male; D010818:Practice Patterns, Physicians'; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D043823:Taxoids / Q000627:therapeutic use*
chemical_list: D000726:Androgen Antagonists; D000970:Antineoplastic Agents; D043823:Taxoids; D000077143:Docetaxel